LNZA LanzaTech Inc.
Price Chart
Executive Summary
LanzaTech entered a multi-year R&D partnership with BRIGHT (DTU) to develop a C1 biofoundry for converting carbon emissions into products. No financial terms were disclosed, so the immediate revenue impact is uncertain.
Actionable Insight
Monitor for future announcements of commercial milestones or licensing deals stemming from this partnership. Without financial details, the stock is unlikely to react significantly.
Key Facts
- Multi-year partnership runs until April 2028
- Partners will design and install a next-generation C1 biofoundry at DTU
- LanzaTech provides non-exclusive IP license and tailored workflows
- No financial terms or specific milestones disclosed
Financial Impact
Undisclosed; partnership is R&D-focused with no immediate revenue contribution
Risk Factors
- No concrete revenue or cost figures provided
- R&D partnerships often have long lead times and uncertain outcomes
- LanzaTech's cash burn and commercial execution remain key risks
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3289030 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 4, 2026
5d ago
|
Press Release
| $6.99 $6.59 | ▼ −5.72% | ▼ −3.12% | $7.26 (+3.86%) |
|
May 27, 2026
13d ago
|
Press Release
| $6.81 $7.08 | ▲ +3.96% | ▲ +3.41% | $7.26 (+6.61%) |
|
May 14, 2026
26d ago
|
Press Release
| $17.15 $9.73 | ▼ −43.27% | ▼ −42.04% | $7.26 (−57.67%) |
|
May 6, 2026
4w ago
|
Press Release
| $22.18 $22.65 | ▲ +2.12% | ▲ +2.45% | $7.26 (−67.27%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access